ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Bone density"

  • Abstract Number: 1975 • ACR Convergence 2020

    Predicting Bone Mineral Density of Lumbar Vertebrae by Assessing Plain Film with Deep Learning

    Chen-I Hsieh1, Chang-Fu Kuo1, Shun Miao2, Kang Zheng2 and Le Lu2, 1Chang Gung Memorial Hospital, Taoyuan, Taiwan (Republic of China), 2PAII labs, Bethesda, MD

    Background/Purpose: Osteoporosis is a silent disease characterized by a decrease in bone mineral density (BMD), causing bone fragility and increased risk of fracture. The most…
  • Abstract Number: 0114 • ACR Convergence 2020

    Incidence of Follow-Up Dual-Energy X-Ray Absorptiometry Scanner Error: A Contributor to Precision Error

    Kevin Lee1, Karam Al Jumaily1, Mu Lin2, Kerry Siminoski3 and Carrie Ye4, 1Internal Medicine, University of Alberta, Edmonton, AB, Canada, 2Alberta Health Services, Edmonton, AB, Canada, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Rheumatology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Osteoporosis is characterized by decreased bone tissue microarchitecture. This leads to reduced bone density and quality and is a significant contributor to morbidity, mortality,…
  • Abstract Number: 0115 • ACR Convergence 2020

    Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project

    Khiem Vu1, Chima Ohadugha1, Kevin Dao1, Rabih Nayfe2 and Andrew Mangano1, 1Grand Strand Medical Center, Myrtle Beach, SC, 2Carolina Health Specialists - Rheumatology, Myrtle Beach, SC

    Background/Purpose: There are known indications for osteoporosis screening in women. However, osteoporosis also occurs in men and fragility fractures are linked to increased morbidity and…
  • Abstract Number: 0125 • ACR Convergence 2020

    A Resident-Led Interdisciplinary Quality Improvement Initiative to Increase Osteoporosis Screening in an Urban Clinic

    Catherine Teskin1 and Hiba Sayed2, 1Christiana Care, Wilmington, 2Christiana Care, wilmington, DE

    Background/Purpose: Osteoporosis is a major cause of morbidity and mortality in the United States. The USPSTF recommends screening all women age 65 and older or…
  • Abstract Number: 0128 • ACR Convergence 2020

    Short-Term Monitoring of Denosumab Effect in Breast Cancer Patients Receiving Aromatase Inhibitors Using Radiofrequency Echographic Multi-Spectrometry (REMS) Technology on Femoral Neck

    Rosachiara Forcignanò1, Fiorella Anna Lombardi2, Mariangela Ciccarese3, Eugenio Quarta4, Antonella Grimaldi5, Laura Quarta5, Delia Ciardo2, Ernesto Casciaro2, Paola Pisani2, Francesco Conversano2, Maurizio Muratore5 and Sergio Casciaro2, 1O.U. of Oncology, “Sacro Cuore di Gesù” Hospital, Gallipoli, Lecce, Italy, Gallipoli, Italy, 2National Research Council, Institute of Clinical Physiology, Lecce, Italy, Lecce, Italy, 3O.U. of Oncology, “Vito Fazzi” Hospital, ASL-LE, Lecce, Italy, Lecce, Italy, 4O.U. of Rheumatology, "Galateo" Hospital, ASL-LE, San Cesario di Lecce, Lecce, Italy, San Cesario di Lecce, Italy, 5O.U. of Rheumatology, “Galateo” Hospital, San Cesario di Lecce ASL-LE, Lecce, Italy, San Cesario di Lecce, Italy

    Background/Purpose: The aim of the study was to carry out a short-term monitoring of the effect of aromatase inhibitors (AI) and Denosumab on bone health…
  • Abstract Number: 1152 • 2019 ACR/ARP Annual Meeting

    Low Rates of Bone Mineral Density Testing by Rheumatologists in Patients with Systemic Lupus Erythematosus and Glucocorticoid Therapy

    JB Boone1, S. Bobo Tanner 1 and April Barnado 1, 1Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) are at an increased risk of developing osteoporosis and clinical fractures compared to healthy controls. Bone loss in…
  • Abstract Number: 2212 • 2019 ACR/ARP Annual Meeting

    Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA

    Dalit Ashany1, Susan Goodman 2, Haley Tornberg 1, Donald McMahon 3, Douglas Mintz 4, Linda Russell 5 and Emily Stein 1, 1Hospital for Special Surgery, New York, NY, 2Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, 3Donald J.McMahon Statistical Consulting, South Nyack, NY, 4Hospital for Special Surgery, Division of Radiology and Imaging, New York, 5Hospital for Special Surgery, New York

    Background/Purpose: Axial Spondyloarthritis (axSpA) is characterized by abnormal bone formation that produces syndesmophytes, while paradoxically, inflammation causes increased bone resorption and skeletal fragility. Detection of…
  • Abstract Number: 2219 • 2019 ACR/ARP Annual Meeting

    Randomized Control Study in Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate or Denosumab (GOBID)

    Ikuko Tanaka1, Mari Ushikubo 2, Misako Konishi 2, Yutaro Hayashi 2, Satoshi Hama 3, Keisuke Izumi 2, Yutaka Okano 2, Shigenori Tamaki 4 and Hisaji Ohshima 2, 1Nagoya Rheumatology Clinic, Ngoya, Japan, 2National Tokyo Medical Center, Tokyo, Japan, 3tokyo medical center, tokyo, Japan, 4Nagoya Rheumatology Clinic, Nagoya, Japan

    Background/Purpose: It has not been established which therapy, bisphosphonates or denosumab, is more effective for glucocorticoid-induced osteoporosis (GIO). The purpose of this study was to…
  • Abstract Number: 2222 • 2019 ACR/ARP Annual Meeting

    Bone Health: An Independent Predictor of Coronary Artery Disease

    Lilian Bizzocchi1, Maria Salgado 1, Bhavin Chokshi 1, Navneet Kaur 1, Oscar Mena 1 and Michal Packman 2, 1Jacobi Medical Center, Bronx, NY, 2North Central Bronx Hospital, Bronx, NY

    Background/Purpose: An association between low bone mineral density (BMD) and cardiovascular events has been shown. The calcification process observed in atherosclerosis and bone mineralization have…
  • Abstract Number: 2228 • 2019 ACR/ARP Annual Meeting

    Rheumatoid Arthritis Disease Activity Is Associated with Low Femoral Neck Bone Mineral Density in a Diverse Cohort of Patients

    Katherine Wysham1, Jonathan Graf 2, Jane Shofer 3, Dennis Black 2, James Andrews 3, Dolores Shoback 2 and Patricia Katz 2, 1Veterans Health Administration Puget Sound, Seattle WA, Seattle, 2University of California, San Francisco, San Francisco, CA, 3University of Washington, Seattle, WA

    Background/Purpose: Rheumatoid arthritis (RA) is an independent risk factor for osteoporosis (OP) and fracture. Although several OP risk factors are well-described in RA, many mechanisms…
  • Abstract Number: 2232 • 2019 ACR/ARP Annual Meeting

    Results of the Implementation of a Bone Health Program in Patients with Rheumatoid Arthritis to Improve the Evaluation of Osteoporosis

    Gabriel Figueroa-Parra1, Rita Pineda-Sic 2, Jairo Rodriguez-Hinojosa 3, Carmen Magdalena Gamboa-Alonso 4, Ana De-Leon-Ibarra 3, Janett Carmen Riega Torres 5, Iván de Jesús Hernández-Galarza 2, Dionicio Galarza-Delgado 2 and Cassandra Skinner Taylor 2, 1Universidad Autónoma de Nuevo León, "Hospital Universitario Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, 2Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico, 3Universidad Autónoma de Nuevo León, "Hospital Universitario Dr. José Eleuterio González", Monterrey, Mexico, 4Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 5Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico

    Background/Purpose: Osteoporosis is a generalized skeletal disorder characterized by compromised bone strength and deterioration of quality, often leading to fragility fractures (1). People with rheumatoid…
  • Abstract Number: 1620 • 2018 ACR/ARHP Annual Meeting

    Lateral DXA More Effective in Detecting Osteoporosis Than Conventional DXA in Axial Spondyloarthropathy

    Gillian Fitzgerald1,2, Jason Wyse3, Tochukwu Anachebe4, Ronan Mullan5, David Kane6, Kevin McCarroll7 and Finbar O' Shea2, 1School of Medicine, Trinity College Dublin, Dublin 2, Ireland, 2Rheumatology, St. James's Hospital, Dublin 8, Ireland, 3School of Computer Science and Statistics, Trinity College Dublin, Dublin 2, Ireland, 4Department of Rheumatology, St. James's Hospital, Dublin 8, Ireland, 5Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, 6Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, 7Department of Medicine for the Elderly, St. James's Hospital, Dublin 8, Ireland

    Background/Purpose: The severe consequences of osteoporosis in the general population are well outlined. In axial spondyloarthropathy (axSpA), osteoproliferation of the spine means posterioanterior (PA) dual-energy…
  • Abstract Number: 2810 • 2018 ACR/ARHP Annual Meeting

    Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated with Abaloparatide Followed By Alendronate

    Benjamin Leder1, Carol Zapalowski2, Ming-Yi Hu3 and Gary Hattersley2, 1Endocrine, Harvard Medical School, Boston, MA, 2Radius Health, Inc., Waltham, MA, 3Biometrics, Radius Health, Inc., Waltham, MA

    Background/Purpose: Abaloparatide (ABL) is an anabolic PTHrP analog approved to treat postmenopausal women with osteoporosis at high risk of fracture. In the ACTIVE Phase 3…
  • Abstract Number: 1731 • 2018 ACR/ARHP Annual Meeting

    Vertebral Fracture Prevalence and Measurement of the Scanographic Bone Attenuation Coefficient on CT-Scan in 70 Patients with Systemic Scleroderma

    Marine FAUNY1, Elodie BAUER2, Eliane ALBUISSON3, Julia Perrier-Cornet1, Joelle DEIBENER4, Francois CHABOT5, Damien MANDRY6, Olivier HUTTIN7, Isabelle Chary-Valckenaere8 and Damien Loeuille2, 1Rheumatology, University Hospital of Nancy, VANDOEUVRE LES NANCY, France, 2Rheumatology, University Hospital of Nancy, NANCY, France, 3University Hospital of Nancy, Nancy, France, 4Internal Medicine, University Hospital of Nancy, NANCY, France, 5Pneumology, University Hospital of Nancy, NANCY, France, 6Radiology, University Hospital of Nancy, NANCY, France, 7Cardiology, University Hospital of Nancy, NANCY, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France

    Background/Purpose: Osteoporosis screening is not systematic in sclerodermic patients but some studies demonstrated a similar risk between rheumatoid arthritis and systemic scleroderma [1,2,3]. Thoracic and/or…
  • Abstract Number: 2811 • 2018 ACR/ARHP Annual Meeting

    Abaloparatide Effect on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis Aged 80 Years or Older

    Susan L. Greenspan1, Lorraine A Fitzpatrick2, Bruce Mitlak2, Yamei Wang2, Nicholas C. Harvey3, Chad Deal4, Felicia Cosman5 and Michael McClung6, 1Medicine, University of Pittsburgh, Pittsburgh, PA, 2Radius Health, Inc., Waltham, MA, 3MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom, 4Cleveland Clinic, Shaker Heights, OH, 5Columbia University College of Physicians and Surgeons, New York, NY, 6Oregon Osteoporosis Center, Portland, OR

    Background/Purpose: The risk of fracture increases with increasing age. Thus, it is important to understand efficacy and safety of osteoporosis treatments in elderly patients. In…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology